天津医药
天津醫藥
천진의약
TIANJIN MEDICAL JOURNAL
2015年
9期
1063-1065
,共3页
胸腔镜手术%引流术%脓胸%尿激酶
胸腔鏡手術%引流術%膿胸%尿激酶
흉강경수술%인류술%농흉%뇨격매
video-assisted thoracoscopic surgery%drainage%empyema%urokinase
目的:观察比较电视辅助胸腔镜手术(VATS)与胸管引流联合尿激酶胸腔注药治疗纤维脓性期肺炎后脓胸的临床效果,以确定此类型脓胸的最佳治疗方案。方法将纤维脓性期脓胸患者按纳入标准和排除标准随机分成2组,VATS组55例,行VATS清理;引流组46例,在B超引导下应用Seldinger法置入12 F导管行胸腔闭式引流,胸腔注入尿激酶10万U,闭管4 h后开放,每天1次,连用3 d。记录各组患者治疗前血白细胞(WBC),胸水pH值、葡萄糖、乳酸脱氢酶(LDH)和C反应蛋白(CRP),治疗后发热持续时间、胸管留置时间、抗生素使用天数、住院天数、治愈率、并发症和住院费用等指标。结果 VATS组治疗后发热持续时间、胸管留置时间、抗生素使用时间、住院天数均短于引流组,治愈率高于引流组(P<0.05)。2组间并发症发生率和住院费用差异无统计学意义。2组均无死亡病例。结论 VATS治疗纤维脓性期肺炎后脓胸的效果优于胸管引流联合尿激酶,未增加并发症和住院费用,值得临床推广。
目的:觀察比較電視輔助胸腔鏡手術(VATS)與胸管引流聯閤尿激酶胸腔註藥治療纖維膿性期肺炎後膿胸的臨床效果,以確定此類型膿胸的最佳治療方案。方法將纖維膿性期膿胸患者按納入標準和排除標準隨機分成2組,VATS組55例,行VATS清理;引流組46例,在B超引導下應用Seldinger法置入12 F導管行胸腔閉式引流,胸腔註入尿激酶10萬U,閉管4 h後開放,每天1次,連用3 d。記錄各組患者治療前血白細胞(WBC),胸水pH值、葡萄糖、乳痠脫氫酶(LDH)和C反應蛋白(CRP),治療後髮熱持續時間、胸管留置時間、抗生素使用天數、住院天數、治愈率、併髮癥和住院費用等指標。結果 VATS組治療後髮熱持續時間、胸管留置時間、抗生素使用時間、住院天數均短于引流組,治愈率高于引流組(P<0.05)。2組間併髮癥髮生率和住院費用差異無統計學意義。2組均無死亡病例。結論 VATS治療纖維膿性期肺炎後膿胸的效果優于胸管引流聯閤尿激酶,未增加併髮癥和住院費用,值得臨床推廣。
목적:관찰비교전시보조흉강경수술(VATS)여흉관인류연합뇨격매흉강주약치료섬유농성기폐염후농흉적림상효과,이학정차류형농흉적최가치료방안。방법장섬유농성기농흉환자안납입표준화배제표준수궤분성2조,VATS조55례,행VATS청리;인류조46례,재B초인도하응용Seldinger법치입12 F도관행흉강폐식인류,흉강주입뇨격매10만U,폐관4 h후개방,매천1차,련용3 d。기록각조환자치료전혈백세포(WBC),흉수pH치、포도당、유산탈경매(LDH)화C반응단백(CRP),치료후발열지속시간、흉관류치시간、항생소사용천수、주원천수、치유솔、병발증화주원비용등지표。결과 VATS조치료후발열지속시간、흉관류치시간、항생소사용시간、주원천수균단우인류조,치유솔고우인류조(P<0.05)。2조간병발증발생솔화주원비용차이무통계학의의。2조균무사망병례。결론 VATS치료섬유농성기폐염후농흉적효과우우흉관인류연합뇨격매,미증가병발증화주원비용,치득림상추엄。
Objective To compare the clinical effect of video-assisted thoracoscopic surgery (VATS) and chest tube drainage combined with urokinase for the treatment of empyema after fibropurulent pneumonia, and to determine the best therapy for patients. Methods Patients were randomly divided into two groups according to inclusion and exclusion crite?ria:55 patients were selected as group VATS performed VATS;46 patients were selected as drainage group performed 12F catheter chest closed drainage by Seldinger technique under B ultrasound guidance. The 100 000 unit urokinase was inject?ed into chest, and open after 4-hour closed, once a day for three days. Values of white blood cell (WBC), pH, glucose, lactate dehydrogenase (LDH) and C reactive protein (CRP) of pleural effusion before treatment were recorded, and the duration of fe?ver after treatment, duration of chest-tube placement, antibiotic use, hospital stay, cure rate, complication and hospitaliza?tion expenses were also recorded. Results The duration of fever after treatment,, duration of chest-tube placement, antibiot?ic use and hospital stay were significantly lower in VATS group than those in drainage group. The cure rate was significantly higher in VATS group than that of drainage group (P<0.05). There were no significant differences in complication rates and hospitalization expenses between two groups. There was no death in both two groups. Conclusion VATS is more suitable for the treatment of empyema after fibropurulent pneumonia than chest tube drainage combined with urokinase, and which is worthy of clinical promotion for not adding complication rates and hospitalization expenses.